Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
about
Maternal immunizationTo B or not to B cells-mediate a healthy start to lifeSpatiotemporal analysis of infant measles using population attributable risk in Shandong province, 1999-2008.Cotreatment of congenital measles with vitamin a and intravenous immunoglobulinWaning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type IaPrevalence of protective measles virus antibody levels in umbilical cord blood samples in Catalonia, SpainLow titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccinationLength of intervals between epidemics: evaluating the influence of maternal transfer of immunityMaternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events.Duration of Maternal Antibodies against Canine Distemper Virus and Hendra Virus in Pteropid Bats.Effectiveness assessment of vaccination policy against measles epidemic in Japan using an age-time two-dimensional mathematical modelRubella immune status of neonates - a window towards seroprevalence among childbearing women.Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.The 2013 measles outbreak in Sri Lanka: experience from a rural district and implications for measles elimination goalsPrevalence of measles in vaccinated and non-vaccinated children.Immunization of pregnant women: Future of early infant protection.Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.Measles vaccination: new strategies and formulations.Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.Maternal immunization to modulate the development of allergic response and pathogen infections.Measles elimination: progress, challenges and implications for rubella control.Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose.Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.Measles Antibodies in Mother-Infant Dyads in Tianjin, China.ELISA for detection of humoral immunity against measles.Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.Ecological and life-history factors influencing the evolution of maternal antibody allocation: a phylogenetic comparison.Vaccine waning and mumps re-emergence in the United States.MeaslesMaternal mumps antibodies in a cohort of children up to the age of 1 yearMeasles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccinationEffect of maternal HIV infection on measles susceptibility during early infancy: implications for optimizing protection of the infant
P2860
Q26853746-1AA68F08-5EB9-4155-ACD9-702943AEF519Q27024986-B20C7A19-90BE-4B08-8676-FC2AE66E8AECQ31144196-2E63624C-8C41-4A99-BAE1-7AF478C976A1Q33419510-D7E68889-22EE-4E55-B91D-DC4B32F7B5D4Q33705199-99466202-1D91-41B1-9F75-C826F7670C43Q33720634-044A0B2E-DCDE-49E6-A1A7-77DE2F54B958Q33768642-8651EF34-5BC2-4A84-B0EA-BBCB794DDD94Q33870082-6070CCC1-2560-4AFE-BF04-E8755B926A59Q33901841-40E6A4C4-87B4-41C8-A1D4-3D237DBFD1CAQ34193265-4BE676E5-BF34-4EAB-94D7-BC093EA24790Q34319379-F53689E6-E27B-440C-BA63-4BEA3539CA89Q34797376-738A2B28-9D85-4978-BC37-70E82981F69DQ35672707-16C6FF1A-ADF3-4338-9DE6-01E9A53609F3Q36108127-ED1CF82C-335F-49FA-BC78-ECC7DD98B867Q36249022-7FAF8553-2B7C-46AB-A5CA-6CC0675D064BQ36340937-9D6774F0-F86B-4E8A-BDA4-46A709EF938AQ36341208-2B95BD89-3A46-40AB-A329-00AB0B0AA591Q36389045-AEA613B1-7491-4FF9-9507-F25E20606136Q36818026-E4B426C9-D8EC-445D-9905-165981FFC573Q36994265-B5DD4C04-6B98-42ED-B44A-71425218B0A1Q37130723-0270C8A0-F710-419C-B7D0-E60C2841B7C6Q37290110-89F70718-885A-4E4E-8A57-609D1B992BE7Q37404944-144885C0-089B-4FF7-BE92-EC27962FB430Q37773283-E8A86035-524D-4470-90B9-B5EBA01EF650Q38132267-757D665F-C135-493D-8E22-E8D71548A42AQ38736019-13343539-561A-4913-BE81-A78D77B4E7A5Q40174032-9C3845BC-9AED-492D-982A-F551C1E162F7Q40779986-E1A89506-C855-4A3E-BA52-6D7DB3C36432Q41992184-4E879AC4-3DCE-4AEF-82E1-763A3609A58CQ42219928-E1C55D7D-7110-41EB-A2C4-11EF949CB6F9Q43097342-C4B86C52-3538-49BF-8C70-4849F7A26E94Q48097810-5526DEFC-9071-4723-B701-5EC30123F551Q50948541-1AC7CCA9-F21B-445A-BFA2-D678B1ACFECBQ51179013-95B496BE-EC32-4525-ACD1-38A86F4EF6ACQ51783238-9AF924E3-3E31-468F-B336-10745A44F29AQ55970012-A9731585-681D-40F1-A22E-2AC9E3347ADCQ56880800-19371554-9723-4725-B697-E9F59E05E513Q57096187-77D2C0A9-09CD-43B9-BFB4-F60812F5EC6CQ58052657-4F49E20D-27CA-44D7-A7D5-91F53E00F4AD
P2860
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Passive transmission and persi ...... s against measles in newborns.
@en
type
label
Passive transmission and persi ...... s against measles in newborns.
@en
prefLabel
Passive transmission and persi ...... s against measles in newborns.
@en
P1433
P1476
Passive transmission and persi ...... es against measles in newborns
@en
P2093
Van Damme P
P304
P356
10.1016/J.VACCINE.2007.06.020
P407
P577
2007-06-29T00:00:00Z